Triviño, J. C.
Ceba, A.
Rubio-Solsona, E.
Serra, D.
Sanchez-Guiu, I.
Ribas, G.
Rosa, R.
Cabo, M.
Bernad, L.
Pita, G.
Gonzalez-Neira, A.
Legarda, G.
Diaz, J. L.
García-Vigara, A.
Martínez-Aspas, A.
Escrig, M.
Bermejo, B.
Eroles, P.
Ibáñez, J.
Salas, D.
Julve, A.
Cano, A.
Lluch, A.
Miñambres, R.
Benitez, J.
Funding for this research was provided by:
IVACE (IMIDTA/2016/75, IMIDTA/2018/7)
H2020 European Research Council (634935)
AVI (INNTAL21/19/002)
Article History
Received: 23 July 2020
Accepted: 28 October 2020
First Online: 10 November 2020
Ethics approval and consent to participate
: Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The present study was submitted to and approved by the Clinical Research Ethics Committee (CEIC) of the Hospital Clínico Universitario de Valencia (Spain), September 29th, 2016 (2016/169) and July 13th, 2018 (2018/139), and was conducted in compliance with the Helsinki Declaration.Informed consent: Written informed consent was obtained from all the participants included in the study at the time of recruitment. Patient information was anonymized and de-identified.This study was approved by the Ethical Committee of Hospital Clínico Universitario de Valencia (Comité Ético de Investigación Clínica) on 29th September 2016 and was assigned the internal project code 2016/169.
: Not applicable.
: The authors declare that they have no competing interests.